Overview

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

Status:
RECRUITING
Trial end date:
2028-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent prostate cancer after focal therapy
Phase:
NA
Details
Lead Sponsor:
Hackensack Meridian Health
Collaborator:
Blue Earth Diagnositcs